Continuum Advisory LLC Decreases Stock Holdings in CME Group Inc. (NASDAQ:CME)

Continuum Advisory LLC lowered its holdings in shares of CME Group Inc. (NASDAQ:CME) by 2.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,014 shares of the financial services provider’s stock after selling 90 shares during the quarter. Continuum Advisory LLC’s holdings in CME Group were worth $593,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Gold Investment Management Ltd. bought a new position in shares of CME Group in the 4th quarter valued at about $26,000. Northwest Financial Advisors purchased a new stake in CME Group during the fourth quarter valued at approximately $28,000. Salomon & Ludwin LLC bought a new stake in shares of CME Group in the 1st quarter valued at approximately $28,000. Rise Advisors LLC purchased a new position in shares of CME Group in the 1st quarter worth approximately $41,000. Finally, McClarren Financial Advisors Inc. increased its position in shares of CME Group by 89.5% during the 1st quarter. McClarren Financial Advisors Inc. now owns 216 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 102 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Up 0.1 %

Shares of CME stock traded up $0.16 on Tuesday, hitting $209.03. The stock had a trading volume of 77,598 shares, compared to its average volume of 1,930,771. CME Group Inc. has a one year low of $190.70 and a one year high of $223.80. The business has a 50 day moving average price of $198.74 and a 200 day moving average price of $207.08. The company has a market cap of $75.26 billion, a PE ratio of 23.76, a P/E/G ratio of 6.27 and a beta of 0.52. The company has a quick ratio of 1.01, a current ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the previous year, the business posted $2.30 EPS. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. Research analysts anticipate that CME Group Inc. will post 9.8 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be given a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.20%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of analyst reports. Piper Sandler lowered their price target on CME Group from $235.00 to $225.00 and set an “overweight” rating for the company in a research report on Thursday, July 25th. Rosenblatt Securities restated a “sell” rating and issued a $187.00 target price (up previously from $185.00) on shares of CME Group in a report on Thursday, April 25th. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Barclays boosted their target price on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Finally, Bank of America increased their price target on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $213.27.

Insider Activity

In related news, Director Daniel R. Glickman sold 650 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $201.44, for a total transaction of $130,936.00. Following the sale, the director now owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other CME Group news, Director Daniel R. Glickman sold 650 shares of the firm’s stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the sale, the director now directly owns 14,008 shares in the company, valued at $2,821,771.52. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the transaction, the director now directly owns 7,163 shares in the company, valued at $1,399,936.72. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.